Global Nucleic Acid Testing Market Opportunities & Forecast 2018-2025 Global Nucleic Acid Testing Market Opportunities & | Page 2

diagnosis, treatment and research activities. Moreover, high adaption of nucleic
acid testing in chronic disease diagnosis and forensic testing will creates huge
opportunity during the forecast period.
Download Sample Brochure : https://www.gmiresearch.com/sample-research-
report.php?rid=124
Rising incidence of infection diseases and growing cancer patients worldwide
are the major factor that increases demand of diagnosis. Molecular Diagnosis
industry adopted nucleic acid testing techniques for fast, reliable and accurate
outcomes which boost the market during the forecast period. In addition,
established healthcare infrastructure and improving reimbursement policy in
developed economies are also driving force to the nucleic acid testing market
growth. Increase in research & development activities across the globe
especially in Asia pacific region creates huge potential revenue during the
forecast period.
Expanding need for nucleic acid testing from blood transfusion centers and blood
donation centers will significantly anchor the whole blood transfusion processes,
which is foreseen to reinforce the development of the worldwide nucleic acid
testing market
Various notable players operating the nucleic acid testing market include Agilent
Technologies, Danaher Corporation, Abbott Laboratories Inc., Becton, Dickinson
and Company, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Illumina
Inc., Thermo Fisher Scientific Inc., Qiagen, and Merck KGaA, among others.
The global nucleic acid testing market has been segmented on the basis of
product type, indication, end user and key geographies. Based on product type,
the market comprises of nucleic acid test kits and consumables. Based on